Yet, the jury at Bristol Crown Court heard within days of the Lapland New Forest attraction opening on the Hampshire-Dorset border, hundreds of disgruntled visitors complained to trading standards officials that they had been ripped off.
Thirty-one companies were rewarded with drug approvals, with the crown going to Pfizer (3 approvals) while Astellas, Forest, Roche and Sanofi, each got 2.